Supplementary Data 2 from High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab

Autor: Timothy A. Chan, Robert J. Motzer, A. Ari Hakimi, Kenichi Nomoto, Yasuhiro Funahashi, Junji Matsui, Yukinori Minoshima, Yusuke Adachi, Pallavi Sachdev, Darren Feldman, Maria I. Carlo, Martin H. Voss, Ritesh Kotecha, Samuel Murray, Ed Reznik, Luc Morris, Doug Hoen, Kate Weiss, Mark Lee, Lynda Vuong, Cristina Valero, Vladimir Makarov, Chirag Krishna, Diego Chowell, Renzo G. DiNatale, Chung-Han Lee
Rok vydání: 2023
Popis: HLA class-I allele data along with mean HED values for the lenvatinib/pembrolizumab and MSK-IMPACT cohorts.
Databáze: OpenAIRE